Skip to content
Search

Latest Stories

RPS to host sessions to help shape response for NHS primary care review

The Royal Pharmaceutical Society (RPS) will be hosting two sessions for members to help them shape response to an NHS review of primary care in England.

The sessions will be held on March 15 and March 24 at 7.00pm and will be open to members working in all settings, including primary and secondary care, RPS stated.


The ‘Fuller Stocktake’ review is focusing on how best primary care, including community pharmacy, can be supported within the emergent Integrated Care Systems (ICSs) to meet the health needs of people in their local areas.

It will cover a range of issues, including:

  • Workforce, including leadership and education
  • Collection and use of data and information
  • Working with communities and how best to engage with them
  • Physical access to care
  • Non-physical access to care including use of technology and remote consultations
  • Governance and decision making which includes local contracting

Commenting on the review, RPS England chair Thorrun Govind said: “This review is an important part of how the government and NHS are examining the future of health and care in England.

“Whether it is delivering more integrated care, utilising new technologies, or developing our workforce, these reforms must have improving patient care at their heart.

“Pharmacists working right across the health service continue to put patients first and I know will play a key role in how we transform services for the future.

“These sessions will help inform our ongoing engagement with the NHS about the Fuller Stocktake and what this means alongside wider changes to the NHS.

“We want to hear from pharmacists working across care settings and I would encourage members to attend.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less